HOXB2 and glioblastoma: Bi et al. [24] revealed that HOXB-AS1 up-regulated the expression of HOXB2 or HOXB3 at the post-transcriptional and transcriptional levels through recruitment of ILF3 to driving the glioblastoma progression, which may be potential therapeutic molecules for patients with glioblastoma.